Cryptome Pharmaceuticals Pty. Ltd. Signs Its First Revenue Generating Agreement With Xantos Biomedicine AG 
10/19/2005 5:09:48 PM

26 May 2005 - Melbourne based Cryptome Pharmaceuticals (ASX:CRP) and leading protein drug discovery company Xantos Biomedicine AG of Germany will collaborate to validate a novel cancer therapeutic lead. Cryptome sees this as the first in an expected series of platform deals.